Post hoc pooled analysis of first-line (1L) pembrolizumab (pembro) for advanced urothelial carcinoma (UC): Outcomes by response at week nine in KEYNOTE-052 and KEYNOTE-361.

Powles T., Alva A. S., Ozguroglu M., O'Donnell P. H., Loriot Y., Csoszi T., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.6, 2022 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 40 Issue: 6
• Publication Date: 2022
• Doi Number: 10.1200/jco.2022.40.6_suppl.519
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
• Istanbul University Affiliated: Yes